Heathly Subjects: Clinical Trials

5 trials for Heathly Subjects, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 3 Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Not applicable1Recruiting 1

Follow this condition Literature Review of Heathly Subjects trials Research Report on Heathly Subjects

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessing the Effectiveness of Heat Adaptation Digital Messages From Primary Care Providers to Their Patients on the Change in Behaviour for Heatwave-related Preparedness
Heat adaptation digital messaging, Non-heat-related digital messaging - Heathly Subjects, Primary Health Care
Not applicableRecruitingHopital Montfort200002025-04-012026-09-18
A Pharmacokinetic Study of the Food Effect on Flonoltinib Maleate Tablets
flunotinib - Heathly Subjects
Phase 1CompletedChengdu Zenitar Biomedical Technology Co., Ltd242024-08-042025-09-26
A Phase I Clinical Study of Flonoltinib Maleate Tablets in Healthy Subjects
Flonoltinib Maleate Tablets, Flonoltinib Maleate Tablets placebo - Heathly Subjects
Phase 1CompletedChengdu Zenitar Biomedical Technology Co., Ltd402024-03-182025-09-23
Clinical Trial to Evaluate Pharmacokinetic Characteristics of MIT-001 After SC Administration in Healthy Subjects
Single subcutaneous administration and Blood collection, Single subcutaneous administration and then IV injection., MIT-001 20mg and 40mg_Multiple administration - Heathly Subjects
Phase 1CompletedMitoImmune Therapeutics402022-05-132023-08-24
Changes in the Posterior Parietal Cortex - Primary Motor Cortex Pathway Induced by Motor Training
Movement Disorders, Heathly Subjects
CompletedNational Institute of Neurological Disorders and Stroke (NINDS)202009-05-142017-07-02

Narrower conditions

Heat Stress Disorders (1)  ·  Movement Disorders (1)  ·  Risk Reduction Behavior (1)

Broader conditions

Behavior (1)  ·  Central Nervous System Diseases (1)  ·  Nervous System Diseases (1)  ·  Wounds and Injuries (1)

Sponsors

Chengdu Zenitar Biomedical Technology Co., Ltd (2)  ·  Hopital Montfort (1)  ·  MitoImmune Therapeutics (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)

Countries

China (2)  ·  Canada (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Xiaolan Yong, bachelor (2)  ·  SeungHwan Lee, MD (1)